Hwu P - Search Results

1

Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma.

Rosenberg SA, Yang JC, Robbins PF, Wunderlich JR, Hwu P, Sherry RM, Schwartzentruber DJ, Topalian SL, Restifo NP, Filie A, Chang R, Dudley ME. Rosenberg SA, et al. Among authors: hwu p. J Immunother. 2003 Sep-Oct;26(5):385-93. doi: 10.1097/00002371-200309000-00001. J Immunother. 2003. PMID: 12973027 Free PMC article.

2

Use of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes.

Hwu P, Schwarz S, Custer M, Smith CA, Mulé JJ, Rosenberg SA. Hwu P, et al. J Immunol Methods. 1992 Jul 6;151(1-2):139-47. doi: 10.1016/0022-1759(92)90112-7. J Immunol Methods. 1992. PMID: 1321199

3

In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor.

Karp SE, Hwu P, Farber A, Restifo NP, Kriegler M, Mulé JJ, Rosenberg SA. Karp SE, et al. Among authors: hwu p. J Immunol. 1992 Sep 15;149(6):2076-81. J Immunol. 1992. PMID: 1517571 Free PMC article.

4

In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.

Hwu P, Yang JC, Cowherd R, Treisman J, Shafer GE, Eshhar Z, Rosenberg SA. Hwu P, et al. Cancer Res. 1995 Aug 1;55(15):3369-73. Cancer Res. 1995. PMID: 7614473

5

Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen.

Treisman J, Hwu P, Minamoto S, Shafer GE, Cowherd R, Morgan RA, Rosenberg SA. Treisman J, et al. Among authors: hwu p. Blood. 1995 Jan 1;85(1):139-45. Blood. 1995. PMID: 7803791 Free article.

6

The use of gene-modified tumor-infiltrating lymphocytes for cancer therapy.

Hwu P, Rosenberg SA. Hwu P, et al. Ann N Y Acad Sci. 1994 May 31;716:188-97; discussion 197-203. doi: 10.1111/j.1749-6632.1994.tb21712.x. Ann N Y Acad Sci. 1994. PMID: 8024194 Review. No abstract available.

7

Upregulation of tumor necrosis factor-alpha production by retrovirally transduced human tumor-infiltrating lymphocytes using trans-retinoic acid.

Treisman J, Hwu P, Yannelli JR, Shafer GE, Cowherd R, Samid D, Rosenberg SA. Treisman J, et al. Among authors: hwu p. Cell Immunol. 1994 Jul;156(2):448-57. doi: 10.1006/cimm.1994.1189. Cell Immunol. 1994. PMID: 8025957

8

The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials.

Hwu P, Rosenberg SA. Hwu P, et al. Cancer Detect Prev. 1994;18(1):43-50. Cancer Detect Prev. 1994. PMID: 8162605 Review.

9

The development of gene therapy for the treatment of cancer.

Rosenberg SA, Anderson WF, Blaese M, Hwu P, Yannelli JR, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Ettinghausen SE, et al. Rosenberg SA, et al. Among authors: hwu p. Ann Surg. 1993 Oct;218(4):455-63; discussion 463-4. doi: 10.1097/00000658-199310000-00006. Ann Surg. 1993. PMID: 8215637 Free PMC article.

10

Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain.

Hwu P, Shafer GE, Treisman J, Schindler DG, Gross G, Cowherd R, Rosenberg SA, Eshhar Z. Hwu P, et al. J Exp Med. 1993 Jul 1;178(1):361-6. doi: 10.1084/jem.178.1.361. J Exp Med. 1993. PMID: 8315392 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

389 results

Search Page

Filters